Powered by

Heart devices lift Abbott Labs to solid quarter

Apr 19, 2018 - Star Tribune (Minneapolis, Minnesota)

Solid sales of insertable heart monitors and insulin pumps helped propel Abbott Laboratories to Wall Street-beating sales and adjusted earnings during the first quarter, as the company reaffirmed expectations to grow earnings by about 14 percent this year.

The Illinois-based maker of medical devices and baby formula reported adjusted earnings of 59 cents per share, a penny better than consensus estimates of analysts. Its $7.39 billion in total revenue, nearly 17 percent above year-ago leve

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox